Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine plus propofol for painless gastroscopy
ChiCTR2500097246Phase 4Not yet recruiting
- Sponsor
- Dazhou Central Hospital
- Start
- Feb 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine, propofol and sufentanil in None (4 arms), sponsored by Dazhou Central Hospital. Primary endpoints: Mean arterial pressure, Heart rate and 1 more. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
oliceridinepropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2500097246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097246.